NCT00381667
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Clayton, Victoria, Australia
- GSK Investigational Site Wellington, New Zealand
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
4,014 public trials
393 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01285180
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +6 more
- Locations
-
- Nycomed Deutschland GmbH Aachen, Germany
- Nycomed Deutschland GmbH Aachen, Germany
- Nycomed Deutschland GmbH Aachen, Germany
- Nycomed Deutschland GmbH Aachen, Germany
NCT00103922
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Tempe, Arizona, United States
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +7 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Glendale, Arizona, United States
Completed
RELOVAIR® Lung Deflation Study
NCT01691885
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site London, United Kingdom
NCT01354782
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Nycomed Investigational Site Beijing, China
NCT00108823
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, COPD, Disease Attributes, +6 more
- Locations
-
- ALTANA Pharma Cities in California, California, United States
- ALTANA Pharma Cities in Colorado, Colorado, United States
- ALTANA Pharma Cities in Florida, Florida, United States
- ALTANA Pharma Cities in Missouri, Missouri, United States
NCT00242294
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Nycomed Japan and Mitsubishi Tanabe Oharma Corporation Osaka, Japan
NCT00246935
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Nycomed in Japan and Mitsubishi Tanabe Pharma Corporation Osaka, Japan
NCT01943552
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 244.2514.86008 Boehringer Ingelheim Investigational Site Chengdu, China
- 244.2514.86006 Boehringer Ingelheim Investigational Site Guangzhou, China
- 244.2514.86007 Boehringer Ingelheim Investigational Site Guangzhou, China
- 244.2514.86010 Boehringer Ingelheim Investigational Site Guangzhou, China